Juluca (dolutegravir / rilpivirine) is an HIV antiretroviral (ARV) tablet that contains two medications. It's not meant for people who have never taken HIV ARVs. Still, it's a good option for people who are well controlled on their current HIV regimen and want to switch to different regimen.
Juluca (dolutegravir / rilpivirine) is an HIV ARV combination medication. It contains two medications that prevent HIV from infecting your cells and making copies of itself.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Yes, Juluca is a complete HIV regimen. For many years, HIV regimens contained at least three HIV ARVs. To lower the risk of long-term side effects, scientists have studied regimens that contain two HIV ARVs. The FDA has approved two, 2-drug regimens at this time, Juluca and Dovato (dolutegravir / lamivudine). In clinical trials, 95% of people continued to have an undetectable viral load after switching to Juluca from a 3-drug regimen.
No, you can't take omeprazole (Prilosec) or other proton pump inhibitors (PPIs) if you're taking Juluca. PPIs decrease (lessen) how much Juluca gets absorbed into your body, so they can't be taken together. There are other acid-lowering medications that you can take with Juluca, such as famotidine (Pepcid AC) and calcium carbonate (Tums). Juluca might not be a good option if you take PPIs daily.
You can take Juluca at any time of the day. It needs to be taken with a meal, so pick a mealtime when you usually eat at a consistent time. You'll want to try to take the medication at the same time every day so the medication levels stay consistent (steady) in your body.
In general, it's not recommended for people living with HIV to breastfeed, due to the risk of passing HIV to the breastfed infant.
There are many different programs that can help you pay for your HIV ARV medications. If you have commercial insurance (like through your employer) and have a high copay, you might qualify for a copay card. If you don't have insurance, you might be able to get the medication straight from the manufacturer. Find out more through the Juluca patient assistance program. If your insurance doesn't cover the medication, they might prefer you to use a different HIV ARV first. Ask your provider, pharmacist, insurance provider, and care team about resources if you ever have difficulty affording your medication.
Juluca (dolutegravir / rilpivirine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
In some rare cases, Juluca (dolutegravir / rilpivirine) can cause severe allergic reactions that can affect your organs and be life-threatening. If you suddenly get a high fever, blistering rash all over your body, swelling in the face, or trouble breathing, stop taking Juluca (dolutegravir / rilpivirine) and contact your provider or get medical help right away.
Some people have changes in their liver tests after starting Juluca (dolutegravir / rilpivirine). It can happen to anyone, but it's more common in people who have some type of liver disease. Your provider will check your liver before you start Juluca (dolutegravir / rilpivirine) and will see if you also have a hepatitis B or hepatitis C infection. After you start the medication, your provider will do regular blood tests to monitor your liver.
Taking dolutegravir, an ARV found in Juluca (dolutegravir / rilpivirine), during your first trimester of pregnancy might raise the risk of neural tube defects for your unborn baby. Your provider might check if you're pregnant before you start Juluca (dolutegravir / rilpivirine). If you're pregnant or trying to become pregnant, talk to your healthcare provider about the safest medication options. If you're currently taking Juluca (dolutegravir / rilpivirine) and don't want to become pregnant, talk to your provider about your options for birth control.
Rilpivirine, one of the HIV ARVs in Juluca (dolutegravir / rilpivirine), has been linked to negative thoughts, depression, and thoughts of suicide. If you or a loved one notices that your mood starts to change while taking Juluca (dolutegravir / rilpivirine), let your provider know. If you start thinking about wanting to harm yourself, get medical attention right away.
Always make sure your healthcare team has a full list of the medications you're taking, including over-the-counter (OTC) medications and supplements. Don't start taking any new medications without talking to your provider or pharmacist first. Many medications can interact with Juluca (dolutegravir / rilpivirine). Some interactions can cause unpleasant side effects, while others can affect how well Juluca (dolutegravir / rilpivirine) works (its antiretroviral activity) and lead to resistance (which can make HIV harder to treat). Your provider might adjust your medications to make sure they're all safe for you to take.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 50mg/25mg of | 30 tablets | $3,618.06 | $120.60 |
The recommended dose is 1 tablet by mouth once a day with a meal. Each tablet contains 50 mg of dolutegravir and 25 mg of rilpivirine.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Juluca (dolutegravir / rilpivirine) will not be safe for you to take.
Treatment of HIV infection in adults and children weighing at least 30 lbs, and: